Jiangsu Aidea Pharmaceutical Co., Ltd. logo

Jiangsu Aidea Pharmaceutical Co., Ltd. (688488)

Market Closed
11 Aug, 06:57
SSE SSE
¥
17. 28
-0.07
-0.4035%
¥
3.48B Market Cap
- P/E Ratio
0.19% Div Yield
10.11M Volume
- Eps
¥ 17.35
Previous Close
Add Transaction
Day Range
17.12 18.1
Year Range
11.4 22.55
Want to track 688488 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688488 closed today lower at ¥17.28, a decrease of -0.4035% from yesterday's close, completing a monthly increase of 33.0254% or ¥4.29. Over the past 12 months, 688488 stock gained 4.6005%.
688488 is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

688488 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Jiangsu Aidea Pharmaceutical Co., Ltd. (688488) FAQ

What is the stock price today?

The current price is ¥17.28.

On which exchange is it traded?

Jiangsu Aidea Pharmaceutical Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688488.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.19%.

What is its market cap?

As of today, the market cap is 3.48B.

Has Jiangsu Aidea Pharmaceutical Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Jiangsu Aidea Pharmaceutical Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Jie Zhang CEO
SSE Exchange
CNE1000041S6 ISIN
CN Country
476 Employees
24 Jun 2021 Last Dividend
- Last Split
- IPO Date

Overview

Jiangsu Aidea Pharmaceutical Co., Ltd. is a pharmaceutical company founded in 2009, focused on the development, production, and sale of pharmaceutical products. The company is located in Yangzhou, China, and has made a name for itself in the pharmaceutical industry by offering a diverse range of healthcare solutions, especially for viral infections and chronic diseases. Their efforts are particularly targeted towards innovation in the treatment of HIV and improvement of diagnostic measures for the same.

Products and Services

  • Ainuovirine Tablets

    This product represents Jiangsu Aidea Pharmaceutical's venture into antiretroviral therapy, specifically designed to combat HIV. Ainuovirine tablets are part of the newer generation of HIV medications aimed at suppressing the virus and improving the quality of life for those living with HIV.

  • Urinary Protein Products

    The company offers a range of products in this category:

    • Crude product/intermediate of Ulinastatin: This is used for conditions requiring protease inhibition, showcasing its utility in treating pancreatitis or as a supportive treatment in cancer therapy.
    • Urinary Kallidinogenase: Aimed at improving blood flow and treating vascular disorders, showcasing the company's interest in cardiovascular health.
    • Urokinase: A critical drug used in the management of blood clots, highlighting Jiangsu Aidea Pharmaceutical’s commitment to lifesaving treatments in emergency medicine and critical care.

  • Sennae Folium Granules

    Derived from senna leaves, these granules are used as a natural laxative. The product emphasizes Jiangsu Aidea Pharmaceutical’s dedication to offering herbal and alternative medicine options alongside their synthetic pharmaceuticals, catering to a broader range of customer needs.

  • HIV Diagnostic Equipment and Reagents

    Understanding the critical importance of early and precise HIV diagnosis, Jiangsu Aidea Pharmaceutical also provides diagnostic equipment and reagents. This not only complements their product line of antiretroviral drugs but also reinforces their commitment to comprehensive care in the treatment and management of HIV.

Contact Information

Address: No. 69, Xinganquan West Road, Yangzhou, China, 225008
Phone: 86 514 8209 0238